Find out how the language proposed in the first revision of the WSIS+20 Zero Draft aligns with our vision of an open, globally connected, secure, and trustworthy Internet for everyone.

Detailed price information for Viridian Therapeutics Inc (VRDN-Q) from The Globe and Mail including charting and trades.

First, an anchor point: male pattern hair loss (androgenetic alopecia, AGA) is primarily genetic and androgen-driven. Diet ...

With winter now in full swing and daylight hours at their shortest, farmers are being encouraged to upgrade lighting systems to help sustain milk yields. Director of DairyLight, Dr Torjus Baalack ...

Viridian seeks Priority Review for veligrotug, aiming for a potential mid-2026 commercial launch if approved. Global phase 3 trials for VRDN-003 in TED are underway, with a BLA submission planned by ...

For millions living with pattern hair loss, existing treatments offer little more than a pause button—delaying progression ...

During the event, Rezolute Chief Commercial Officer, Sunil Karnawat, will discuss the anticipated commercial opportunities for ersodetug as a potential treatment for congenital and tumor HI. In ...

The government has budgeted to spend GH¢302.5 billion for the 2026 fiscal year, representing 18.9 per cent of Gross Domestic Product (GDP).

Detailed price information for Zai Lab Ltd ADR (ZLAB-Q) from The Globe and Mail including charting and trades.

We tested the RAD-1 to see if it really performs as both a running shoe and a cross-trainer—and the results impressed us.

Paltusotine vs placebo is associated with normalized insulin-like growth factor-1 (IGF-I), stable pituitary tumor size, significant symptom improvement, and sustained IGF-I reduction among adults with ...

Discover how strategic reductions in dietary protein can trigger powerful cellular repair pathways, lower pro-aging signals, ...